Company Filing History:
1 out of 832,912 Years Active: 2013
Title: The Innovative Mind of Jiaming Li: A Patented Breakthrough in Pharmaceutical Chemistry
Introduction: Jiaming Li, an inventive chemist based in Hefei, China, has made significant contributions to the field of pharmaceutical chemistry. With a focus on unique compounds and their applications, he holds a noteworthy patent that represents both his creativity and expertise in the industry.
Latest Patents: Jiaming Li's most recent patent is titled "4-((3, 5, 6-trimethylpyrazine-2-yl)methoxyl)benzoic acid and its derivatives - Ligustrazine aromatic acid ether derivative of general formula I." This innovative work details the preparation method, pharmaceutical composition, and application of the compound. Key aspects of the patent include selections for aryl groups and hydrogen or alkyl groups with no more than 6 carbon atoms. This patent emphasizes the potential therapeutic applications of his discoveries and serves as a foundation for future research in pharmaceutical development.
Career Highlights: Throughout his career, Jiaming Li has demonstrated a strong commitment to innovation in the chemistry sector. His work on various compounds has garnered attention for its relevance in drug formulation, showcasing his ability to bridge the gap between scientific research and practical application.
Collaborations: Jiaming Li has had the opportunity to collaborate with esteemed colleagues such as Guangwei He and Yonghai Zhao. Their collective expertise has undoubtedly enhanced their research efforts, leading to breakthroughs that push the boundaries of pharmaceutical sciences.
Conclusion: Jiaming Li stands out as a promising inventor with a keen focus on developing innovative pharmaceutical compounds. His patent work not only showcases his scientific talents but also paves the way for future collaborations and advancements in the field. As he continues to explore new ideas and technologies, the impact of his inventions will likely grow, influencing both the pharmaceutical community and the health sector at large.